CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.
April 25th 2022
The drug, known as BDTX-1535, is being investigated in patients with glioblastoma that harbors EGFR alterations and non-small cell lung cancer that harbors EGFR mutations of intrinsic or acquired resistance and disease that has failed standard treatment.
April 18th 2022
The plan to launch the phase 1 trial to evaluate the safety and efficacy of combining the CAR-T cell therapy and oncolytic virus in patients with recurrent glioblastoma, a type of brain cancer, is supported by interim data from two ongoing trials.
March 28th 2022
The study authors plan to enroll 24 patients with glioblastoma, an aggressive brain tumor, to assess the efficacy an investigational drug plus Libtayo prior to surgery to remove the tumor.
February 7th 2022
A phase 2b clinical trial evaluating the efficacy and safety of an immunotherapy drug for patients with brain cancer has opened at Roswell Park Comprehensive Cancer Center in Buffalo, New York, with additional plans to be carried out at more than a dozen sites.
February 2nd 2022
A brain cancer survivor explains how she found a way to navigate her cancer journey as a traveler, grateful to be alive.
January 16th 2022
A brain tumor survivor explains how she chooses to approach life with acceptance of the hard times rather than trying to throw them away.
January 3rd 2022
Patients with a common brain tumor subtype that expresses ERK1/2 activation may obtain a greater survival benefit with PD-1 immunotherapy, although research needs to confirm whether this can be observed in all patients.
December 29th 2021
From celebrity deaths to exciting new treatments, here is CURE®’s roundup of what made waves in the brain cancer space this year.
December 23rd 2021
Upon recognizing the 50th anniversary of the National Cancer Act of 1971, President Joe Biden set forth his proposal for the Advanced Research Projects Agency for Health.
November 5th 2021
From the deaths of Jovita Moore and Jerry Remy due to cancer, to Boyd Huppert’s myeloma diagnosis, here’s what’s happening in the cancer landscape this week.
October 27th 2021
When a patient’s cancer spreads to the brain, their original cancer type may predict what region of the brain the metastasis occurs in, according to new findings. The research could lead to better treatment approaches in the future.
October 14th 2021
Brain metastases are a pattern of spread we are seeing more for many tumor types as patients are living longer with metastatic cancer and we more readily use an array of brain imaging technologies when needed.
August 13th 2021
The FDA granted approval to Welireg for the treatment of patients with von Hippel-Lindau-associated kidney cancer, CNS hemangioblastomas and pancreatic neuroendocrine tumors.
June 14th 2021
The vaccine significantly improved a survival outcome over standard-of-care treatment in patients with newly diagnosed glioblastoma.
May 14th 2021
A long-term brain cancer survivor shares the story of his cancer journey and where it led his life.
May 14th 2021
In honor of Brain Cancer Awareness Month, CURE® spoke with an expert about the latest advances that researchers are working on for patients with this disease.
April 30th 2021
From a mural of Chadwick Boseman in a Los Angeles children’s hospital to the death of Apollo 11 astronaut Michael Collins, here’s what’s happening in the cancer landscape this week.
April 16th 2021
From a 5-year-old with brain cancer celebrating his final round of radiation at a hockey game to a cancer diagnosis for Exodus drummer Tom Hunting, here’s what’s happening in the cancer landscape this week.
April 16th 2021
The FDA has recommended the manufacturer of a cell-based immunotherapy terminate a phase 2 clinical trial assessing its effectiveness in recurrent or progressive glioblastoma early and pursue a phase 3 trial which may lead to an approval.